⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1571276 | 0.79 | — | — | |
| Taurolidine SCHEMBL15234448 | 0.76 | ADRA2B (0.75) | — | |
| SCHEMBL20523360 | 0.75 | CXCR4 (0.40) | — | |
| SCHEMBL223473 | 0.71 | — | — | |
| SCHEMBL7790096 | 0.68 | — | — | |
| Methane SCHEMBL11799024 | 0.65 | — | — | |
| SCHEMBL3639333 | 0.65 | — | — | |
| SCHEMBL27172 | 0.65 | — | — | |
| SCHEMBL20523242 | 0.63 | CXCR4 (0.40) | — | |
| SCHEMBL6353022 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612375-B2 | Antimicrobial and anticancer agents | Persevere Therapeutics Inc. (US) | 2026-04-28 | — | — | US | claimed |
| US-12534443-B2 | Processes for preparing oxathiazin-like compounds | GEISTLICH PHARMA AG (CH) | 2026-01-27 | — | — | US | claimed |
| EP-4615464-A1 | COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND TAURINE FOR USE IN PREVENTION OR TREATMENT OF JOINT DISORDERS | Société des Produits Nestlé S.A. (CH) | 2025-09-17 | — | — | EP | claimed |
| EP-4615435-A1 | COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND TAURINE | Société des Produits Nestlé S.A. (CH) | 2025-09-17 | — | — | EP | claimed |
| US-20250144111-A1 | TAUROLIDINE TREATMENT FOR MYC-EXPRESSING TUMORS IN MAMMALIAN BODIES | CORMEDIX INC (US) | 2025-05-08 | — | — | US | claimed |
| US-20240368097-A1 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | GEISTLICH PHARMA AG (CH) | 2024-11-07 | — | — | US | claimed |
| US-12053478-B2 | Taurultam, taurinamide and methylene glycol treatment for MYC—expressing tumors in mammalian bodies | CORMEDIX INC. (US) | 2024-08-06 | — | — | US | claimed |
| US-20240199563-A1 | ANTIMICROBIAL AND ANTICANCER AGENTS | GEISTLICH PHARMA AG (CH) | 2024-06-20 | — | — | US | claimed |
| US-11999709-B2 | Processes for preparing oxathiazin-like compounds | GEISTLICH PHARMA AG (CH) | 2024-06-04 | — | — | US | claimed |
| WO-2024099885-A1 | COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND TAURINE FOR USE IN PREVENTION OR TREATMENT OF JOINT DISORDERS | Société des Produits Nestlé S.A. (CH) | 2024-05-16 | — | — | WO | claimed |
| WO-1990006138-A1 | IMPLANT FOR USE IN BONE SURGERY | ED GEISTLICH SÖHNE AG FÜR CHEMISCHE INDUSTRIE (CH) | 1990-06-14 | — | — | WO | claimed |
| WO-1990001955-A1 | CHEMICAL COMPOUNDS | ED GEISTLICH SÖHNE AG FÜR CHEMISCHE INDUSTRIE (CH) | 1990-03-08 | — | — | WO | claimed |
| US-4882149-A | Pharmaceutical depot preparation | ED. GEISTLICH SOHNE A.G. FUR CHEMISCHE INDUSTRIE (CH) | 1989-11-21 | — | — | US | claimed |
| EP-0253662-A1 | Pharmaceutical compositions | ED. GEISTLICH SÖHNE AG FÜR CHEMISCHE INDUSTRIE (CH) | 1988-01-20 | — | — | EP | claimed |
| WO-1986007265-A1 | PHARMACEUTICAL DEPOT PREPARATION | ED. GEISTLICH SOHNE A.G. FÜR CHEMISCHE INDUSTRIE (CH) | 1986-12-18 | — | — | WO | claimed |
| US-4626536-A | Compositions for combatting toxaemia | ED GEISTLICH SOHNE AG FUR CHEMISCHE/INDUSTRIE (CH) | 1986-12-02 | — | — | US | claimed |
| US-4604391-A | Treatment of osteitis and osteomyelitis employing thiadiazine compounds | ED GEISTLICH SOHNE AG FUR CHEMISCHE INDUSTRIE (CH) | 1986-08-05 | — | — | US | claimed |
| EP-0147021-A1 | Pharmaceutical composition | ED. GEISTLICH SÖHNE AG FÜR CHEMISCHE INDUSTRIE (CH) | 1985-07-03 | — | — | EP | claimed |
| EP-0139535-A2 | Compositions for combatting toxaemia | ED. GEISTLICH SÖHNE AG FÜR CHEMISCHE INDUSTRIE (CH) | 1985-05-02 | — | — | EP | claimed |
| EP-0139534-A2 | Compositions for the prophylactic treatment of osteitis and osteomyelitis | ED. GEISTLICH SÖHNE AG FÜR CHEMISCHE INDUSTRIE (CH) | 1985-05-02 | — | — | EP | claimed |